Reappraising long-term antiplatelet therapy after percutaneous coronary intervention - Authors' reply.

Kang J, Yang HM, Park S, Park KW, Kim HS

Open source

DOI
10.1016/s0140-6736(26)01369-3
Published
2026 Aug 22
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01369-3,
  title = {Reappraising long-term antiplatelet therapy after percutaneous coronary intervention - Authors' reply.},
  author = {Kang J and Yang HM and Park S and Park KW and Kim HS},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01369-3},
  url = {https://doi.org/10.1016/s0140-6736(26)01369-3}
}

RIS

TY  - JOUR
TI  - Reappraising long-term antiplatelet therapy after percutaneous coronary intervention - Authors' reply.
AU  - Kang J
AU  - Yang HM
AU  - Park S
AU  - Park KW
AU  - Kim HS
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01369-3
UR  - https://doi.org/10.1016/s0140-6736(26)01369-3
ER  - 

APA

J, K., HM, Y., S, P., KW, P., & HS, K. (2026). Reappraising long-term antiplatelet therapy after percutaneous coronary intervention - Authors' reply.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01369-3

Source records